news
FDA approves expanded label for Namzaric in Alzheimer’s disease
20 July 2016 | By Victoria White, Digital Content Producer
The US Food and Drug Administration (FDA) has approved an expanded label for Namzaric.
List view / Grid view
Adamas
List view / Grid view
20 July 2016 | By Victoria White, Digital Content Producer
The US Food and Drug Administration (FDA) has approved an expanded label for Namzaric.
